Black Diamond Therapeutics (BDTX) Q4 2024 Earnings

Nov 5Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.47
-0.4
-0.34
-0.28

Details

Expected EPS
-0.373343
Actual EPS
-0.28
Surprise EPS
0.09
Surprise Percent
+25%

Description

⁨Black Diamond Therapeutics⁩ (⁦BDTX⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts